Patrick J. Loehrer
Researcher Next ID · RN-021789
Researcher · Medicine
Indianapolis, Kenya
- Works count
- 544
- Citation count
- 26,424
- H-index
- 81
- i10-index
- 241
Research interests
Publications
The Integrated Genomic Landscape of Thymic Epithelial Tumors
Cancer Cell · 2018 · 10.1016/j.ccell.2018.01.003
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
The Lancet Oncology · 2015 · 10.1016/s1470-2045(14)71181-7
Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma
Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.32.9607
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.34.8904
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
Yearbook of Oncology · 2008 · 10.1016/s1040-1741(08)79037-7
Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
Journal of Clinical Oncology · 2008 · 10.1200/jco.2008.21.2134
Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor
Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.10.182
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002
Gastrointestinal Endoscopy · 2002 · 10.1016/s0016-5107(02)70351-9
Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma
Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.16.2972
Thymoma: State of the Art
Journal of Clinical Oncology · 1999 · 10.1200/jco.1999.17.7.2280
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
New England Journal of Medicine · 1998 · https://doi.org/10.1056/nejm199810083391504
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.
Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.7.2500
Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.
Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.4.1287
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
Journal of Clinical Oncology · 1997 · https://doi.org/10.1200/jco.1997.15.7.2564
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
Journal of Clinical Oncology · 1995 · 10.1200/jco.1995.13.2.470
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.
Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.11.2264
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.6.1164
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
Journal of Clinical Oncology · 1992 · https://doi.org/10.1200/jco.1992.10.7.1066
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
Journal of Clinical Oncology · 1991 · 10.1200/jco.1991.9.7.1163
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
Journal of Clinical Oncology · 1989 · 10.1200/jco.1989.7.7.932
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
Journal of Clinical Oncology · 1989 · 10.1200/jco.1989.7.3.387
Salvage Therapy in Recurrent Germ Cell Cancer: Ifosfamide and Cisplatin plus Either Vinblastine or Etoposide
Annals of Internal Medicine · 1988 · 10.7326/0003-4819-109-7-540
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
New England Journal of Medicine · 1987 · 10.1056/nejm198706043162302
Cisplatin
Annals of Internal Medicine · 1984 · 10.7326/0003-4819-100-5-704
The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases
Cancer · 1984 · 10.1002/1097-0142(19841101)54:9<1824::aid-cncr2820540910>3.0.co;2-j
Current projects
No projects listed.